Remi Adelaiye-Ogala

4PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2026
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.

Surendra Gulla, Tej Sharma, Ephraim Gardner

|Nov 29, 2023
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer.

Lynda Bennett, Praveen Kumar Jaiswal, Ryan V Harkless

|Nov 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.

Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala

|May 07, 2020
Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor.

Remi Adelaiye-Ogala, Berkley E Gryder, Yen Thi Minh Nguyen

Pageof 1